Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about SNY

Recent news which mentions SNY

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
29 30 Next >
Sanofi (SNY) Q3 2022 Earnings Call Transcript
Tickers SNY
Tags SNY Market News Recent Press Releases
From Motley Fool
Dupixent, Flu Vaccine Demand Boost Sanofi's Q3 Earnings, Lifts Annual Outlook
Tickers SNY
Tags Large Cap Eurasia Benzinga
From Benzinga
Sanofi: Q3 Earnings Insights
Tickers SNY
Tags Market News BZI/Recaps Benzinga
From Benzinga
Earnings Scheduled For October 28, 2022
Tickers AB ABBV AC AON
Tags CRTO DTM BLMN
From Benzinga
Sanofi posts higher sales but $2.07 billion net profit misses forecasts
Tickers SNY
Tags SNY FR:SAN
From MarketWatch
Sanofi's Earnings Outlook
Tickers SNY
Tags Benzinga Market News Earnings
From Benzinga
3 Dividend Stocks That Could Soar 51% to 58%, According to Wall Street
Tickers MPW PFE SNY ZTS
Tags Market News PFE MPW
From Motley Fool
US Stock Futures Lower Following Friday's Rally; Tesla In Focus
Tickers AVEO AZN CCK DFS
Tags Global AVEO Markets
From Benzinga
New Drugs Approvals Bring No Relief for Ailing Innovent Bio
Tickers ASIA BGNE LLY SNY
Tags Benzinga BGNE SNY
From Benzinga
2 High-Yielding Dividend Stocks That Haven't Been This Cheap in Years
Tickers INTC SNY
Tags INTC Market News Recent Press Releases
From Motley Fool
3 Red-Hot Stocks That Could Continue to Beat the Market
Tickers AXSM JAZZ REGN SNY
Tags Market News AXSM VRTX
From Motley Fool
Sanofi - Regeneron Tout Additional Positive Data From Flagship Dupixent Product
Tickers REGN SNY
Tags News Market News Health Care
From Benzinga
2 Top Healthcare Stocks to Buy Right Now
Tickers ABT REGN SNY
Tags ABT SNY Market News
From Motley Fool
7 Under-$50 Stocks to Buy to Tap Into a Hidden Bull Market
Tickers BA BAC EADSY GM
Tags Market News Stocks to Buy UL
From InvestorPlace
Sanofi, Provention Bio Ink Co-Promotion Pact For Type 1 Diabetes Treatment Candidate
Tickers PRVB SNY
Tags FDA News Contracts
From Benzinga
Sanofi In-Licenses Preclinical Genetic Disease Candidate From An Unknown Biotech
Tickers SNY
Tags News Contracts Market News
From Benzinga
Here's Why the Post-Pandemic World May Be Even Better for This Vaccine Maker
Tickers MRNA PFE SNY
Tags SNY Market News Recent Press Releases
From Motley Fool
Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis
Tickers REGN SNY
Tags FDA News Market News
From Benzinga
Haleon Shares Pop After Rejecting Zantac Indemnification Requests From GSK, Pfizer
Tickers GSK HLN PFE SNY
Tags News PFE Market News
From Benzinga
Multiple Sclerosis Is A Crowded Space, But This Stock Is A Potential 6X Multi-bagger
Tickers IMUX RHHBY SNY
Tags General Analyst Ratings Price Target
From Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
Tickers BMY PFE REGN SNY
Tags Recent Press Releases PFE REGN
From Motley Fool
AstraZeneca's COVID-19 Antibody Cocktail, RSV Treatment For Infants Gets European Authority Backing
Tickers AZN AZNCF SNY
Tags News Market News AZNCF
From Benzinga
ASLAN Pharma Starts Eblasakimab Program In Dupixent Treated Dermatitis Patients
Tickers ASLN REGN SNY
Tags ASLN General News
From Benzinga
What's Moderna's Next Billion-Dollar Market? The Answer May Surprise You.
Tickers MRNA SNY
Tags SNY Recent Press Releases MRNA
From Motley Fool
Regeneron-Sanofi Eczema Drug Shows Improvements In Itchy Inflammatory Skin Disease
Tickers REGN SNY
Tags News Market News General
From Benzinga
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
Tickers AZN BNTX GSK MRNA
Tags Briefs SNY Biotech
From Benzinga
Sanofi-Regeneron's Flagship Drug Shows Consistent Efficacy, Safety Profile At Two Years For Asthma In Kids
Tickers REGN SNY
Tags SNY Briefs Biotech
From Benzinga
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash...
Tickers AMD AMZN BA BABA
Tags Health Care MSFT Benzinga
From Benzinga
Sanofi's Rare Disease Drug Xenpozyme Scores FDA Approval
Tickers SNY
Tags Genetic Disease Biotech SNY
From Benzinga
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
Tickers ACAD AMGN AMLX AXSM
Tags FENC CRMD General
From Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.